<unk>  is used for osteoporosis to decrease the risk of fractures. Two trials found that it reduced the rate of vertebral fracture. In one, there was a 73% lower risk of vertebral fracture after one year, and the benefit was maintained after a second year of taking denosumab. In the other, one year of<unk>  followed by one year of alendronate had a 50% vertebral fracture reduction compared to two years of alendronate.
Romosozumab
Emapalumab
Evolocumab
Olaratumab
Tralokinumab
Ustekinumab
Burosumab
Bezlotoxumab